Sign Up Today and Learn More About Apnimed Stock
Invest in or calculate the value of your shares in Apnimed or other pre-IPO companies through EquityZen's platform.
Apnimed Stock (APNI)
Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders.
About Apnimed Stock
Founded
2017
Headquarters
Cambridge, MA, US
Industries
Real Estate, Software, Artificial Intelligence
Apnimed Press Mentions
Stay in the know about the latest news on Apnimed
Once-nightly oral pill helps control obstructive sleep apnea
news-medical • May 19, 2026
Apnimed's sleep apnea pill meets main goal in late-stage study
tradingview • May 18, 2026
Apnimed Announces Publication of its Phase 3 SynAIRgy Trial of AD109 for Obstructive Sleep Apnea in the American Journal of Respiratory and Critical Care Medicine
prnewswire • May 18, 2026
Apnimed Announces Publication of its Phase 3 SynAIRgy Trial of AD109 for Obstructive Sleep Apnea in the American Journal of Respiratory and Critical Care Medicine
biospace • May 18, 2026
Apnimed's sleep apnea pill meets main goal in late-stage study
marketscreener • May 18, 2026
Apnimed Management
Leadership team at Apnimed
Founder, CEO & Board Chair
Lawrence G. Miller
Co-Founder and Medical Director
Luigi Taranto Montemurro
Join now and verify your accreditation status to gain access to:
- Apnimed Current Valuation
- Apnimed Stock Price
- Apnimed Management
- Available deals in Apnimed and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Apnimed Cap Table and Funding History by Share Class and Liquidity Preferences
- Apnimed Revenue and Financials
- Apnimed Highlights
- Apnimed Business Model
- Apnimed Risk Factors
- Apnimed Research Report from SACRA Research
Trading Apnimed Stock
How to invest in Apnimed stock?
Accredited investors can buy pre-IPO stock in companies like Apnimed through EquityZen funds. These investments are made available by existing Apnimed shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Apnimed stock?
Shareholders can sell their Apnimed stock through EquityZen's private company marketplace. EquityZen's network includes over 460K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 54K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
